In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Peter J Grant
Speaker
Peter J Grant
Peter J Grant Peter J Grant

University of Leeds, Leeds (United Kingdom of Great Britain & Northern Ireland)

Specialities : Risk Factors and Prevention , Risk Factors and Prevention

9 presentations from this speaker

ESC Webinars Series - Diabetes. Focus 1: Management of diabetes and pre-diabetes with cardiovascular disease.

Event : Webinar 2020

  • Session : ESC Webinars 2020
  • Speaker : A Ceriello (Barcelona,ES), OV Sivakova (Moscow,RU), PJ Grant (Leeds,GB)

Key recommendations from the Guidelines.

Event : ESC Congress 2019

  • Session : Meet the Task Force 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the European Association for the Study of Diabetes (EASD)
  • Speaker : PJ Grant (Leeds,GB)

Diabetes treatment in ischemic heart disease – Key messages.

Event : ESC Congress 2018

  • Session : Key messages from the most popular ESC webinars
  • Speaker : N Marx (Aachen,DE), PJ Grant (Leeds,GB)
  • ESC Education committee

Debate: what can we conclude about the safety profile of DPP-4 inhibitors in post-ACS T2D patients?

Event : ESC Congress 2015

  • Session : Management priorities and clinical outcomes in post-acute coronary syndrome (ACS) patients with type 2 diabetes (T2D)
  • Speaker : F Zannad (Vandoeuvre,FR), V Menon (Cleveland,US), PJ Grant (Leeds,GB)
  • Sponsored by Takeda Pharmaceuticals GmbH

Management perspectives for the post-ACS T2D patient: cardiologist vs diabetologist (Part 1 & Part 2).

Event : ESC Congress 2015

  • Session : Management priorities and clinical outcomes in post-acute coronary syndrome (ACS) patients with type 2 diabetes (T2D)
  • Speaker : V Menon (Cleveland,US), PJ Grant (Leeds,GB)
  • Sponsored by Takeda Pharmaceuticals GmbH

Diabetes in cardiovascular disease: questions and answers to the panellists.

Event : ESC Congress 2013

  • Session : Meet the Guidelines Task Force II
  • Speaker : L Ryden (Stockholm,SE), PJ Grant (Leeds,GB)

Diabetes, pre-diabetes in cardiovascular disease.

Event : ESC Congress 2013

  • Session : ESC Guidelines 2013 overview
  • Speaker : L Ryden (Stockholm,SE), PJ Grant (Leeds,GB)

Introduction.

Event : ESC Congress 2013

  • Session : ESC Guidelines on diabetes, pre-diabetes and cardiovascular disease
  • Speaker : PJ Grant (Leeds,GB)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are